Search

Your search keyword '"Souto Maior AP"' showing total 2 results
Start Over Author "Souto Maior AP" Topic antineoplastic agents
2 results on '"Souto Maior AP"'

1. Favorable outcome of severe, extensive, granulocyte colony-stimulating factor-induced, corticosteroid-resistant Sweet's syndrome treated with high-dose intravenous immunoglobulin.

Author

Calixto R, Menezes Y, Ostronoff M, Sucupira A, Botelho LF, Florencio R, Martins M, and Souto Maior AP

Subjects
Adult, Biopsy, Humans, Male, Multiple Myeloma diagnosis, Remission Induction, Severity of Illness Index, Skin pathology, Sweet Syndrome chemically induced, Sweet Syndrome diagnosis, Treatment Outcome, Adrenal Cortex Hormones therapeutic use, Antineoplastic Agents adverse effects, Drug Resistance, Granulocyte Colony-Stimulating Factor adverse effects, Immunoglobulins, Intravenous therapeutic use, Multiple Myeloma drug therapy, Skin drug effects, Sweet Syndrome drug therapy
Published
2014
Full Text
View/download PDF

2. Safety of fractionated dose of rituximab in renal failure patients receiving hemodialysis.

Author

Ostronoff F, Ostronoff M, Florêncio R, Matias C, Souto Maior AP, Domingues MC, Calixto R, Sucupira A, Matias K, and Tagliari C

Subjects
Aged, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Fatal Outcome, Female, Humans, Lymphoma, Non-Hodgkin complications, Male, Middle Aged, Remission Induction, Rituximab, Venous Thrombosis complications, Antibodies, Monoclonal administration & dosage, Antineoplastic Agents administration & dosage, Lymphoma, Non-Hodgkin drug therapy, Renal Dialysis methods, Renal Insufficiency drug therapy
Published
2006

Catalog

Books, media, physical & digital resources
See catalog results